The Food and Drug Administration had recently approved a new drug for the treatment of atopic dermatitis (eczema), which can ...

Xite Practice Sales is proud to announce the successful sale of a Freestanding Emergency Room (ER)Center in Houston, Texas, to a rapidly expanding health insurance company with a ...

The Massachusetts Department of Elementary and Secondary Education (DESE) recently announced its partnership with leading K-12 digital curriculum provider Imagine Learning to implement Small Group ...

Arash Mostaghimi, MD, MPA, MPH, assistant professor of dermatology, director of the inpatient dermatology consult service, and codirector of the Complex Medical Dermatology Fellowship at Brigham & ...

The US Food and Drug Administration has approved Ebglyss (lebrikizumab-lbkz) for adults and children aged 12 years and older with moderate-to-severe atopic dermatitis.

Jazz and Werewolf's aim is to position WTX-613 as a safer alternative tipping the risk-to-benefit balance back in favour of treatment when used as both a monotherapy and in combination with other ...